NWWA
TEVA icon

New Wave Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

New Wave Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$516K Sell
17,127
-6,917
-29% -$223K 0.18% 96
2025
Q4 		$750K Buy
24,044
+1,084
+5% +$26.7K 0.27% 71
2025
Q3 		$464K Buy
+22,960
New +$403K 0.18% 91

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New Wave Wealth Advisors's TEVA Position: Q1 2026 in Review

New Wave Wealth Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 29% in Q1 2026, selling an estimated $223K and leaving 17,127 shares worth $516K. The position accounts for 0.18% of the portfolio, ranked #96.

New Wave Wealth Advisors first reported a position in TEVA in Q3 2025 and has held it in 3 quarters since. The position peaked at $750K in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • New Wave Wealth Advisors held 17,127 shares of Teva Pharmaceuticals worth $516K as of Q1 2026.
  • New Wave Wealth Advisors sold 6,917 Teva Pharmaceuticals shares in Q1 2026, an estimated $223K.
  • Teva Pharmaceuticals made up 0.18% of New Wave Wealth Advisors's portfolio in Q1 2026, its #96 holding.
  • New Wave Wealth Advisors first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • New Wave Wealth Advisors's Teva Pharmaceuticals position peaked at $750K in Q4 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on New Wave Wealth Advisors's 13F filing for Q1 2026, filed 4 May 2026.